Allergan Pulls A Fast One | In the Pipeline 

Awful, as far as I’m concerned. Awful on several levels. For one, this is not how the patent system (for all its flaws) is supposed to work. “The validity of your patents is subject to review, unless you pay off some Indian tribe” does not seem like a good way to run an intellectual property system.

View the most recent posts on Hobo Signs by Macdrifter or all of the posts in the archive.